ProMIS Neurosciences Inc. (PMN) stock
PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.29−0.19 (-5.46%)
Close on Nov 13, 2026Market cap $29.50MP/E –Yield –
ProMIS Neurosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ProMIS Neurosciences's enterprise value was -$19.74M on Nov 11, 2026, against -$881.70K a year earlier. Over the last 5 years it ranged from -$23.78M to $63.74M, with a median of $23.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$19.74M | – |
| 2025 | Dec 31, 2025 | -$741.79K | -107.9% |
| 2024 | Dec 31, 2024 | $9.41M | +113.8% |
| 2023 | Dec 29, 2023 | $4.40M | -83.9% |
| 2022 | Dec 30, 2022 | $27.28M | – |
See a number that looks wrong?